Carbylan Therapeutics Lands $5,000,000 New Financing

  • Feed Type
  • Date
    10/14/2014
  • Company Name
    Carbylan Therapeutics
  • Mailing Address
    3181 Porter Drive Palo Alto, CA 94304 USA
  • Company Description
    Carbylan Therapeutics develops and markets bioresponsive medical products to enhance healing, provide better surgical outcomes and improve patients’ quality of life. Carbylan is committed to quality in all areas of its business by complying with regulatory requirements and improving the effectiveness of its quality system.
  • Website
    http://www.carbylan.com
  • Transaction Type
    Debt
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy